Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Type I Complex Regional Pain Syndrome

In brief

Complex Regional Pain Syndrome (CRPS) / Complex Regional Pain Syndrome (CRPS) is a chronic neurological disorder that affects the extremities and is characterized by disabling pain, swelling, vasomotor instability, sudomotor abnormality, and impaired motor function; the duration and clinical magnitude is greater than expected, being divided into three stages of progression over time: Stage I: acute (0-3 months); Stage II: dystrophic (3-9 months); Stage 3: atrophic (9-18 months). The purpose of this study is to investigate the effect on complex pain syndrome using a conventional care protocol plus the application of non-invasive neuromodulation during compared to the effect of the same protocol plus placebo.

Key facts

Study ID

NCT05052736

Run by

University of Las Palmas de Gran Canaria

People needed

42

Starts

2022-03-28

Expected to finish

2026-12-27

Last updated by the study team

2025-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet the Budapest criteria for the clinical diagnosis of CRPS type I.
• Age between 18 and 65.
• Period between 0 and 6 months after the onset of the clinical picture.
• Have signed the informed consent of their own free will.

You may not qualify if…

• Have a diagnosis of CRPS type II.
• Present type I CRPS in more than one limb.
• Patients who have suffered a recurrence of CRPS type I.
• Pregnancy or plans for it during the study.
• Previous sympathectomy in the affected limb.

Where it is running

• Aníbal Báez Suárez — Las Palmas de Gran Canaria, Palmas, Las, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.